$547.59
-0.46-0.08%
At close: Aug 24, 5:00 PM EST
$547.59
N/A
After Hours: 4:00 PM EST
Vertex Pharmaceuticals Inc Earnings Estimates
VRTXNASDAQ
Vertex Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRTX
Vertex Pharmaceuticals (VRTX) is scheduled to report Q3 earnings on November 2, 2026. Analysts estimate EPS of $4.81 and quarterly revenue of $3.39B.
In the most recent quarter (Q2), Vertex Pharmaceuticals reported EPS of $4.73, beating estimates of $4.63 by 0.02%. Revenue came in at $3.33B, exceeding the estimate of $3.21B by 0.04%.
Vertex Pharmaceuticals has beaten EPS estimates in 5 consecutive quarters.
Over the last 4 quarters, Vertex Pharmaceuticals has averaged an EPS surprise of 0.06% and a revenue surprise of 0.01%.
Earnings Date
Nov 2
EPS Estimate
$4.810
Quarterly Revenue Estimate
$3.39B
Annual Revenue
$12.59B
as of Jun 30
Vertex Pharmaceuticals Earnings History
Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.
Vertex Pharmaceuticals (VRTX) Earnings Per Share
The chart below shows Vertex Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Vertex Pharmaceuticals (VRTX) Revenue
The chart below shows Vertex Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on November 2, 2026. The last reported earnings were for reported on August 3, 2026 for Q2.
What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?
The Actual EPS was $4.73, which beat the estimate of $4.63.
What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?
The Actual Revenue was $3.33B, which beat the estimate of $3.21B.
